Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
J Surg Oncol19 Feb 2024

Liver Resection Outperforms Ablation in Multifocal Hepatocellular Carcinoma

Examining T2 multifocal hepatocellular carcinoma (MHCC), researchers compared liver resection (LR) and tumor ablation (TA) in a cohort of 1225 patients. Despite higher 30-day mortality with LR, 10-year overall survival favored LR over TA (27.5% vs. 14.7%). Stratified analysis revealed significant benefits in patients with…

Gastroenterology17 Feb 2024

Cell neighborhoods in pancreatic ductal adenocarcinoma impact clinical outcomes

Cell neighborhoods within the tumor microenvironment of pancreatic ductal adenocarcinoma (PDA) play a crucial role in determining clinical outcomes. Researchers used immunohistochemistry and image analysis to study cell neighborhoods in PDA tumors from chemotherapy-naïve and chemotherapy-treated patients. They found that distinct intratumoral immune and tumor…

Gastrointest Endosc15 Feb 2024

Study Finds Adverse Events Associated with Single Operator Cholangioscopy System

Analysis of the MAUDE database reveals that the single operator cholangioscopy (SOC) system, specifically the SpyGlass DS and DS II devices, carries additional risks compared to standard endoscopic retrograde cholangiopancreatography. The study identifies 2,331 device problems reported between January 2016 and August 2023, with optical…

Ann Surg Oncol15 Feb 2024

Salvage Surgery Improves Overall Survival Rates in Unresectable Hepatocellular Carcinoma Patients

Among patients with initially unresectable hepatocellular carcinoma (uhcc), combination therapy with transcatheter arterial chemoembolization, lenvatinib, and anti-PD-1 antibodies achieved high tumor response rates and converted some cases to resectable disease. A retrospective study compared outcomes in uhcc patients who underwent salvage surgery (sr group) versus…